Many studies have shown that ERBB3 contributes to tumourigenesis, proliferation, and cell survival in cancer.35 Downstream signalling of these RTKs revealed that the phosphorylation of ERK, p38, and AKT were markedly down‐regulated. The gene discussed is EPHB2; the disease is cancer.